{
  "trial_id": "NCT01153568",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Ambulatory women older than 60 years of age",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "20 nmol/L < serum 25(OH)D level < 65 nmol/L",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Willingness to take study drug and participate for four years in the trial",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Use of medications that influence bone metabolism (e.g. anticonvulsants)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Significant deviation from normal in either: history, physical examination or laboratory tests as evaluated by the Principle Investigator",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Participation in another investigational trial 30 days prior to screening",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Serum 25(OH)D levels \u2264 20 nmol/L or \u2265 65 nmol/L",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "BMD total hip below - 2.5 standard deviation (using NHANES III adult young white men and women as the point of reference) or history of osteoporotic fracture",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient has Paget's Disease of Bone, but no other exclusion criteria are mentioned.",
  "_meta": {
    "topic_id": "40",
    "trial_id": "NCT01153568",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}